Cellectar Biosciences CLRB
NASDAQ CLRB
$1.87 +0.03 (+1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT

Cellectar Biosciences (CLRB) Accumulated Depreciation (2018 - 2023)

Updated

Cellectar Biosciences (CLRB) reported Accumulated Depreciation of $884,909 for Q4 2023, up 27.8% from $692,534 a year earlier.

Analysis

Cellectar Biosciences (CLRB) Accumulated Depreciation (2018 - 2023) Analysis & Trends

Dating back to Q4 2018, Cellectar Biosciences' Accumulated Depreciation record includes 6 quarters.

  • Accumulated Depreciation has increased for five consecutive years, with a five-year compound annual growth rate of 37.3% (FY2018 to FY2023).
  • By year, Accumulated Depreciation came in at $692,534 in FY2022 (+27.1%), $544,776 in FY2021 (+35.0%), $403,673 in FY2020 (+30.5%) and $309,405 in FY2019 (+70.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cellectar Biosciences 22.51 Mn 22.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 884,909.00
Dec 31, 2022 692,534.00
Dec 31, 2021 544,776.00
Dec 31, 2020 403,673.00
Dec 31, 2019 309,405.00
Dec 31, 2018 181,192.00
API Access

Cellectar Biosciences Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=CLRB&period=max&api_key=YOUR_API_KEY